Kercheville Advisors, LLC Pfizer Inc Transaction History

Kercheville Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $22,230 - $27,137	-508 Reduced 2.5%	19,797 $866,000
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $3,675 - $4,358	79 Added 0.39%	20,305 $1.07 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $29,554 - $36,621	-646 Reduced 3.1%	20,226 $1.05 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $240,812 - $356,965	-5,828 Reduced 21.83%	20,872 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $282,600 - $363,024	7,200 Added 36.92%	26,700 $1.15 Million
Q2 2021 Nov 15, 2021	BUY	$35.91 - $40.68 $18,673 - $21,153	520 Added 2.74%	19,500 $764,000
Q1 2021 Nov 15, 2021	SELL	$33.49 - $37.77 $920,573 - $1.04 Million	-27,488 Reduced 59.15%	18,980 $687,000
Q4 2020 Nov 12, 2021	BUY	$33.47 - $42.56 $1.56 Million - $1.98 Million	46,468 New	46,468 $1.7 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.